Efzofitimod Promotes Macrophages with Anti-inflammatory Profile via Neuropilin-2 Receptor

Keystone Symposia: Myeloid Cell Diversity, 2024

« Efzofitimod, a First-in-Class NRP2-Targeting Immunomodulator, Ameliorates Rheumatoid Arthritis and Associated Lung Fibrosis in Preclinical Models

© 2007 - 2024 aTyr Pharma. Legal Privacy Policy